

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | heme biosynthetic process (GO:0006783) | 6.90567517 |
| 2 | DNA deamination (GO:0045006) | 6.82287246 |
| 3 | angiotensin maturation (GO:0002003) | 6.81140310 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 5.85620608 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 5.78771274 |
| 6 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.76712308 |
| 7 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.72766225 |
| 8 | heme metabolic process (GO:0042168) | 5.68889174 |
| 9 | NADH metabolic process (GO:0006734) | 5.68797878 |
| 10 | intestinal absorption (GO:0050892) | 5.62072003 |
| 11 | plasma lipoprotein particle assembly (GO:0034377) | 5.61945991 |
| 12 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.54363619 |
| 13 | viral transcription (GO:0019083) | 5.47612770 |
| 14 | porphyrin-containing compound biosynthetic process (GO:0006779) | 5.40947348 |
| 15 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.38918803 |
| 16 | diacylglycerol metabolic process (GO:0046339) | 5.35646817 |
| 17 | translational termination (GO:0006415) | 5.33608277 |
| 18 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.33222336 |
| 19 | protein-lipid complex assembly (GO:0065005) | 5.28953712 |
| 20 | phospholipid efflux (GO:0033700) | 5.03938775 |
| 21 | lipoprotein transport (GO:0042953) | 4.99809368 |
| 22 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.97239313 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 4.96727608 |
| 24 | tetrapyrrole biosynthetic process (GO:0033014) | 4.84512810 |
| 25 | translational elongation (GO:0006414) | 4.81957007 |
| 26 | protein autoprocessing (GO:0016540) | 4.80735074 |
| 27 | proteasome assembly (GO:0043248) | 4.78970034 |
| 28 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.74667981 |
| 29 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.74176499 |
| 30 | DNA replication initiation (GO:0006270) | 4.73829096 |
| 31 | cotranslational protein targeting to membrane (GO:0006613) | 4.63048409 |
| 32 | protein targeting to ER (GO:0045047) | 4.61974994 |
| 33 | transepithelial transport (GO:0070633) | 4.56996857 |
| 34 | one-carbon compound transport (GO:0019755) | 4.53390359 |
| 35 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.49489775 |
| 36 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.49489775 |
| 37 | DNA strand elongation (GO:0022616) | 4.48498967 |
| 38 | erythrocyte maturation (GO:0043249) | 4.45841388 |
| 39 | porphyrin-containing compound metabolic process (GO:0006778) | 4.45639687 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.45069584 |
| 41 | protein localization to endoplasmic reticulum (GO:0070972) | 4.43725812 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 4.41765850 |
| 43 | ribosomal small subunit biogenesis (GO:0042274) | 4.41528650 |
| 44 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.40894958 |
| 45 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.39315321 |
| 46 | fructose metabolic process (GO:0006000) | 4.28146058 |
| 47 | GDP-mannose metabolic process (GO:0019673) | 4.26532034 |
| 48 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.22508525 |
| 49 | maturation of SSU-rRNA (GO:0030490) | 4.21918146 |
| 50 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.21883958 |
| 51 | translational initiation (GO:0006413) | 4.21176125 |
| 52 | DNA replication checkpoint (GO:0000076) | 4.16888975 |
| 53 | hemidesmosome assembly (GO:0031581) | 4.16283475 |
| 54 | pseudouridine synthesis (GO:0001522) | 4.14704857 |
| 55 | telomere maintenance via recombination (GO:0000722) | 4.12299318 |
| 56 | deoxyribonucleotide biosynthetic process (GO:0009263) | 4.12210330 |
| 57 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.12151446 |
| 58 | viral life cycle (GO:0019058) | 4.11051153 |
| 59 | folic acid metabolic process (GO:0046655) | 4.09531776 |
| 60 | cellular protein complex disassembly (GO:0043624) | 4.08691139 |
| 61 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.01476576 |
| 62 | CENP-A containing nucleosome assembly (GO:0034080) | 3.99891484 |
| 63 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.97992035 |
| 64 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.97992035 |
| 65 | homocysteine metabolic process (GO:0050667) | 3.97502949 |
| 66 | oxidative phosphorylation (GO:0006119) | 3.95698469 |
| 67 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.91897630 |
| 68 | purine ribonucleotide transport (GO:0015868) | 3.83390218 |
| 69 | chromatin remodeling at centromere (GO:0031055) | 3.81857065 |
| 70 | translation (GO:0006412) | 3.79134222 |
| 71 | epoxygenase P450 pathway (GO:0019373) | 3.77997994 |
| 72 | regulation of autophagic vacuole assembly (GO:2000785) | 3.75425461 |
| 73 | adenine nucleotide transport (GO:0051503) | 3.72507535 |
| 74 | iron-sulfur cluster assembly (GO:0016226) | 3.69266068 |
| 75 | metallo-sulfur cluster assembly (GO:0031163) | 3.69266068 |
| 76 | ribosomal large subunit biogenesis (GO:0042273) | 3.68995116 |
| 77 | formation of translation preinitiation complex (GO:0001731) | 3.68232585 |
| 78 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.64475761 |
| 79 | ATP synthesis coupled proton transport (GO:0015986) | 3.64475761 |
| 80 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.63596517 |
| 81 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.61429632 |
| 82 | mitotic recombination (GO:0006312) | 3.60211462 |
| 83 | lysine catabolic process (GO:0006554) | 3.56840044 |
| 84 | lysine metabolic process (GO:0006553) | 3.56840044 |
| 85 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.56426335 |
| 86 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.53081009 |
| 87 | regulation of cellular extravasation (GO:0002691) | 3.52740038 |
| 88 | protein complex disassembly (GO:0043241) | 3.49222202 |
| 89 | reverse cholesterol transport (GO:0043691) | 3.46916083 |
| 90 | pigment biosynthetic process (GO:0046148) | 3.46684112 |
| 91 | glycosphingolipid catabolic process (GO:0046479) | 3.46116889 |
| 92 | virion attachment to host cell (GO:0019062) | 3.45972536 |
| 93 | adhesion of symbiont to host cell (GO:0044650) | 3.45972536 |
| 94 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.45229303 |
| 95 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.45041697 |
| 96 | telomere maintenance via telomere lengthening (GO:0010833) | 3.44717196 |
| 97 | glucose 6-phosphate metabolic process (GO:0051156) | 3.43307126 |
| 98 | protein targeting to mitochondrion (GO:0006626) | 3.42958088 |
| 99 | DNA replication-independent nucleosome organization (GO:0034724) | 3.42003795 |
| 100 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.42003795 |
| 101 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.40844202 |
| 102 | endocrine process (GO:0050886) | 3.40844202 |
| 103 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.40844202 |
| 104 | spliceosomal snRNP assembly (GO:0000387) | 3.39719976 |
| 105 | sulfate transmembrane transport (GO:1902358) | 3.39690159 |
| 106 | lipoprotein metabolic process (GO:0042157) | 3.39568348 |
| 107 | protein-lipid complex remodeling (GO:0034368) | 3.38524436 |
| 108 | macromolecular complex remodeling (GO:0034367) | 3.38524436 |
| 109 | plasma lipoprotein particle remodeling (GO:0034369) | 3.38524436 |
| 110 | drug metabolic process (GO:0017144) | 3.35597133 |
| 111 | rRNA modification (GO:0000154) | 3.33226793 |
| 112 | glycolipid catabolic process (GO:0019377) | 3.32997427 |
| 113 | urea cycle (GO:0000050) | 3.31358299 |
| 114 | macromolecular complex disassembly (GO:0032984) | 3.30986362 |
| 115 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.30781827 |
| 116 | regulation of mitochondrial translation (GO:0070129) | 3.30726504 |
| 117 | adhesion of symbiont to host (GO:0044406) | 3.29825750 |
| 118 | positive regulation of osteoblast proliferation (GO:0033690) | 3.29340475 |
| 119 | oligosaccharide catabolic process (GO:0009313) | 3.29130008 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 3.28528286 |
| 121 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.27236459 |
| 122 | regulation of systemic arterial blood pressure (GO:0003073) | 3.25719174 |
| 123 | protein-lipid complex subunit organization (GO:0071825) | 3.24679025 |
| 124 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.23203339 |
| 125 | erythrocyte development (GO:0048821) | 3.22382398 |
| 126 | rRNA processing (GO:0006364) | 3.22153351 |
| 127 | establishment of protein localization to mitochondrion (GO:0072655) | 3.21494999 |
| 128 | glutathione biosynthetic process (GO:0006750) | 3.21367676 |
| 129 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.21329999 |
| 130 | gas transport (GO:0015669) | 3.21235805 |
| 131 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.20867755 |
| 132 | ribosome biogenesis (GO:0042254) | 3.20634829 |
| 133 | purine nucleotide transport (GO:0015865) | 3.20555045 |
| 134 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.19670335 |
| 135 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.18797953 |
| 136 | urea metabolic process (GO:0019627) | 3.18736787 |
| 137 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.18117938 |
| 138 | DNA unwinding involved in DNA replication (GO:0006268) | 3.17402313 |
| 139 | desmosome organization (GO:0002934) | 3.16657502 |
| 140 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.15333652 |
| 141 | cholesterol efflux (GO:0033344) | 3.15017941 |
| 142 | termination of RNA polymerase III transcription (GO:0006386) | 3.13601650 |
| 143 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.13601650 |
| 144 | regulation of vitamin metabolic process (GO:0030656) | 3.13578732 |
| 145 | tetrapyrrole metabolic process (GO:0033013) | 3.11542307 |
| 146 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.10837939 |
| 147 | rRNA metabolic process (GO:0016072) | 3.10389184 |
| 148 | positive regulation of lipid catabolic process (GO:0050996) | 3.10136835 |
| 149 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.10061532 |
| 150 | protein targeting to membrane (GO:0006612) | 3.09886373 |
| 151 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.08199683 |
| 152 | cellular component biogenesis (GO:0044085) | 3.07827555 |
| 153 | protein localization to mitochondrion (GO:0070585) | 3.07340022 |
| 154 | mannose metabolic process (GO:0006013) | 3.07210275 |
| 155 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.06067100 |
| 156 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.04702271 |
| 157 | tRNA methylation (GO:0030488) | 3.03609879 |
| 158 | mRNA catabolic process (GO:0006402) | 3.03425103 |
| 159 | regulation of cGMP biosynthetic process (GO:0030826) | 3.03414702 |
| 160 | regulation of cholesterol homeostasis (GO:2000188) | 3.01917434 |
| 161 | sphingosine metabolic process (GO:0006670) | 3.01541656 |
| 162 | regulation of protein heterodimerization activity (GO:0043497) | 3.01298849 |
| 163 | peptide catabolic process (GO:0043171) | 3.00220243 |
| 164 | histone mRNA metabolic process (GO:0008334) | 2.98576186 |
| 165 | pigment metabolic process (GO:0042440) | 2.98462674 |
| 166 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.97113190 |
| 167 | NIK/NF-kappaB signaling (GO:0038061) | 2.96585689 |
| 168 | vitamin A metabolic process (GO:0006776) | 2.96506931 |
| 169 | spliceosomal complex assembly (GO:0000245) | 2.96443827 |
| 170 | regulation of vacuole organization (GO:0044088) | 2.95863869 |
| 171 | nitrogen cycle metabolic process (GO:0071941) | 2.95308156 |
| 172 | bile acid and bile salt transport (GO:0015721) | 2.94539151 |
| 173 | proline biosynthetic process (GO:0006561) | 2.94437581 |
| 174 | antimicrobial humoral response (GO:0019730) | 2.94275309 |
| 175 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.93336094 |
| 176 | protein retention in ER lumen (GO:0006621) | 2.91916705 |
| 177 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.91632712 |
| 178 | renal system process involved in regulation of blood volume (GO:0001977) | 2.88381711 |
| 179 | antibacterial humoral response (GO:0019731) | 2.85855308 |
| 180 | regulation of cholesterol metabolic process (GO:0090181) | 2.83346384 |
| 181 | L-ascorbic acid metabolic process (GO:0019852) | 2.82739012 |
| 182 | hormone catabolic process (GO:0042447) | 2.82654287 |
| 183 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.81266352 |
| 184 | positive regulation of pseudopodium assembly (GO:0031274) | 2.80732048 |
| 185 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.79369149 |
| 186 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.78569211 |
| 187 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.75431446 |
| 188 | leukotriene metabolic process (GO:0006691) | 2.74250456 |
| 189 | negative regulation of lipase activity (GO:0060192) | 2.72132950 |
| 190 | auditory receptor cell differentiation (GO:0042491) | 2.71889407 |
| 191 | polyol transport (GO:0015791) | 2.68178236 |
| 192 | sulfate transport (GO:0008272) | 2.67633674 |
| 193 | granulocyte differentiation (GO:0030851) | 2.66932634 |
| 194 | cellular response to zinc ion (GO:0071294) | 2.66851650 |
| 195 | vitamin transport (GO:0051180) | 2.65226037 |
| 196 | cholesterol homeostasis (GO:0042632) | 2.63749482 |
| 197 | arachidonic acid metabolic process (GO:0019369) | 2.63624088 |
| 198 | regulation of bile acid biosynthetic process (GO:0070857) | 2.62334715 |
| 199 | nucleoside transport (GO:0015858) | 2.62327809 |
| 200 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.59902605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.10778351 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 5.24783719 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.54201611 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.39511254 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.42204939 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.33489006 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.25249495 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.11121414 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.07206580 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.04125458 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.86833443 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.83082573 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.71910392 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.64866424 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.62946522 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.59166359 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.58847830 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.57565736 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.41782250 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41419471 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.39925193 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.39867254 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.38936383 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.31944353 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.28771541 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.27850920 |
| 27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.25025339 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.23259978 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15542266 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.15247568 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.13334533 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.11897915 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.11179704 |
| 34 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.10668962 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10313287 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.09859789 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 2.02155912 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.01827185 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.01236915 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.01114495 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.99974871 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.95243920 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.94024930 |
| 44 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.92041785 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.91240966 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.86879562 |
| 47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.83030321 |
| 48 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.79155354 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78826082 |
| 50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.78432934 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76841158 |
| 52 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.75803067 |
| 53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.75387329 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74042866 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.73941009 |
| 56 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.72063551 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70216142 |
| 58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.68598919 |
| 59 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.66907891 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66349219 |
| 61 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.66116133 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.65758776 |
| 63 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.65479527 |
| 64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64091156 |
| 65 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.63597872 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.63205859 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.61644518 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61203435 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59762111 |
| 70 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.59546053 |
| 71 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.58525151 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58123832 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57969634 |
| 74 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.54275006 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54081717 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.53914524 |
| 77 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.51991884 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51287376 |
| 79 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.47711677 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47624459 |
| 81 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.47314076 |
| 82 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47201859 |
| 83 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.46847475 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 1.46140717 |
| 85 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.45697523 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44977004 |
| 87 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.44890642 |
| 88 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.44603514 |
| 89 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.44521212 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.43570255 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43097377 |
| 92 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42980886 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41391536 |
| 94 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41261292 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.40621106 |
| 96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.39747416 |
| 97 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38586406 |
| 98 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37180860 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37051950 |
| 100 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35209535 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.35131260 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34707397 |
| 103 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34594184 |
| 104 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.33663918 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33489878 |
| 106 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33338315 |
| 107 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.33143968 |
| 108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.32503740 |
| 109 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.32053579 |
| 110 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31490690 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.31204424 |
| 112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30234429 |
| 113 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29741626 |
| 114 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.29523207 |
| 115 | MAF_26560356_Chip-Seq_TH2_Human | 1.28625673 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28310696 |
| 117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28022259 |
| 118 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27690124 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25901150 |
| 120 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24028376 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23754769 |
| 122 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22305337 |
| 123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22278975 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.22038250 |
| 125 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.21381666 |
| 126 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20937885 |
| 127 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20707490 |
| 128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19053228 |
| 129 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18942809 |
| 130 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.18886824 |
| 131 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18243128 |
| 132 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.16987174 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16814013 |
| 134 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.16427123 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16054162 |
| 136 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15855012 |
| 137 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15041368 |
| 138 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14157186 |
| 139 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13421582 |
| 140 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11321461 |
| 141 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10904155 |
| 142 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10902732 |
| 143 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10390863 |
| 144 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09493030 |
| 145 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08636526 |
| 146 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08375798 |
| 147 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08189000 |
| 148 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07871465 |
| 149 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07329530 |
| 150 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05883939 |
| 151 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05824145 |
| 152 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04717080 |
| 153 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04241736 |
| 154 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04213565 |
| 155 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.04109709 |
| 156 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03883340 |
| 157 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03822529 |
| 158 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03542929 |
| 159 | MAF_26560356_Chip-Seq_TH1_Human | 1.02629620 |
| 160 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02332631 |
| 161 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01365655 |
| 162 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01105983 |
| 163 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00955506 |
| 164 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00556869 |
| 165 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99900082 |
| 166 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99815297 |
| 167 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99369313 |
| 168 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.99134830 |
| 169 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98965227 |
| 170 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98710715 |
| 171 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95859951 |
| 172 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95575467 |
| 173 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94300797 |
| 174 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93380445 |
| 175 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93164772 |
| 176 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93015223 |
| 177 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89141757 |
| 178 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88513687 |
| 179 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88157756 |
| 180 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.87737379 |
| 181 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.86975846 |
| 182 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.86743757 |
| 183 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.84973999 |
| 184 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83385998 |
| 185 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.83222335 |
| 186 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.81733309 |
| 187 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81511758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 7.08344573 |
| 2 | MP0004147_increased_porphyrin_level | 6.97019858 |
| 3 | MP0006054_spinal_hemorrhage | 6.73489598 |
| 4 | MP0009840_abnormal_foam_cell | 5.85389255 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.66545487 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.63828121 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 3.45856732 |
| 8 | MP0001545_abnormal_hematopoietic_system | 3.36012010 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 3.36012010 |
| 10 | MP0010094_abnormal_chromosome_stability | 3.07204624 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.97646879 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.89541436 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.78180452 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.69400829 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.69239129 |
| 16 | MP0008057_abnormal_DNA_replication | 2.67032179 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.61783614 |
| 18 | MP0005409_darkened_coat_color | 2.61537687 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 2.57692469 |
| 20 | MP0000678_abnormal_parathyroid_gland | 2.49420371 |
| 21 | MP0003077_abnormal_cell_cycle | 2.46029616 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 2.38799741 |
| 23 | MP0008058_abnormal_DNA_repair | 2.37742651 |
| 24 | MP0003186_abnormal_redox_activity | 2.37482487 |
| 25 | MP0003183_abnormal_peptide_metabolism | 2.36284863 |
| 26 | MP0000490_abnormal_crypts_of | 2.31230903 |
| 27 | MP0002132_abnormal_respiratory_system | 2.24772872 |
| 28 | MP0005365_abnormal_bile_salt | 2.11558303 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 2.11454947 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.10905738 |
| 31 | MP0005636_abnormal_mineral_homeostasis | 1.87695755 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.83772169 |
| 33 | MP0001849_ear_inflammation | 1.81875058 |
| 34 | MP0005451_abnormal_body_composition | 1.80451665 |
| 35 | MP0006035_abnormal_mitochondrial_morpho | 1.72425519 |
| 36 | MP0003436_decreased_susceptibility_to | 1.71409394 |
| 37 | MP0008007_abnormal_cellular_replicative | 1.71290409 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.65498227 |
| 39 | MP0002796_impaired_skin_barrier | 1.61624085 |
| 40 | MP0009379_abnormal_foot_pigmentation | 1.60310957 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.59044300 |
| 42 | MP0005332_abnormal_amino_acid | 1.58998606 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.58365232 |
| 44 | MP0004858_abnormal_nervous_system | 1.57108751 |
| 45 | MP0002249_abnormal_larynx_morphology | 1.54744884 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.49373038 |
| 47 | MP0008932_abnormal_embryonic_tissue | 1.49183095 |
| 48 | MP0004043_abnormal_pH_regulation | 1.46213250 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.45948899 |
| 50 | MP0003724_increased_susceptibility_to | 1.45758733 |
| 51 | MP0001664_abnormal_digestion | 1.41812014 |
| 52 | MP0002098_abnormal_vibrissa_morphology | 1.39144836 |
| 53 | MP0001188_hyperpigmentation | 1.36966376 |
| 54 | MP0000538_abnormal_urinary_bladder | 1.34350179 |
| 55 | MP0000579_abnormal_nail_morphology | 1.31718834 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.28896267 |
| 57 | MP0002398_abnormal_bone_marrow | 1.23860157 |
| 58 | MP0001853_heart_inflammation | 1.23771748 |
| 59 | MP0008260_abnormal_autophagy | 1.23453498 |
| 60 | MP0000313_abnormal_cell_death | 1.18970667 |
| 61 | MP0005257_abnormal_intraocular_pressure | 1.18110203 |
| 62 | MP0003878_abnormal_ear_physiology | 1.17786111 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 1.17786111 |
| 64 | MP0002722_abnormal_immune_system | 1.17051089 |
| 65 | MP0000358_abnormal_cell_content/ | 1.16636318 |
| 66 | MP0002822_catalepsy | 1.13124183 |
| 67 | MP0008789_abnormal_olfactory_epithelium | 1.12673209 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.12445365 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.11134740 |
| 70 | MP0005666_abnormal_adipose_tissue | 1.08716705 |
| 71 | MP0000350_abnormal_cell_proliferation | 1.08610725 |
| 72 | MP0001216_abnormal_epidermal_layer | 1.06725764 |
| 73 | MP0003786_premature_aging | 1.05586377 |
| 74 | MP0002136_abnormal_kidney_physiology | 1.05430746 |
| 75 | MP0001764_abnormal_homeostasis | 1.04172113 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.04049110 |
| 77 | MP0003303_peritoneal_inflammation | 1.03506212 |
| 78 | MP0001730_embryonic_growth_arrest | 1.01760912 |
| 79 | MP0003763_abnormal_thymus_physiology | 1.01485475 |
| 80 | MP0004947_skin_inflammation | 1.00104299 |
| 81 | MP0001661_extended_life_span | 0.99431009 |
| 82 | MP0002429_abnormal_blood_cell | 0.98233162 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.95373000 |
| 84 | MP0008872_abnormal_physiological_respon | 0.92958386 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.92581521 |
| 86 | MP0001765_abnormal_ion_homeostasis | 0.92431177 |
| 87 | MP0000467_abnormal_esophagus_morphology | 0.92323660 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 0.91843873 |
| 89 | MP0001243_abnormal_dermal_layer | 0.91720692 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.91041455 |
| 91 | MP0005375_adipose_tissue_phenotype | 0.90948849 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.90286541 |
| 93 | MP0002080_prenatal_lethality | 0.89573082 |
| 94 | MP0002102_abnormal_ear_morphology | 0.89017954 |
| 95 | MP0003718_maternal_effect | 0.88611845 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.87503907 |
| 97 | MP0000003_abnormal_adipose_tissue | 0.86224826 |
| 98 | MP0000377_abnormal_hair_follicle | 0.83647398 |
| 99 | MP0005394_taste/olfaction_phenotype | 0.82842600 |
| 100 | MP0005499_abnormal_olfactory_system | 0.82842600 |
| 101 | MP0000566_synostosis | 0.82577095 |
| 102 | MP0005075_abnormal_melanosome_morpholog | 0.81985078 |
| 103 | MP0001663_abnormal_digestive_system | 0.81829749 |
| 104 | MP0004270_analgesia | 0.81368087 |
| 105 | MP0000749_muscle_degeneration | 0.81329932 |
| 106 | MP0005266_abnormal_metabolism | 0.81185416 |
| 107 | MP0009764_decreased_sensitivity_to | 0.81064251 |
| 108 | MP0002060_abnormal_skin_morphology | 0.78717698 |
| 109 | MP0008469_abnormal_protein_level | 0.77835648 |
| 110 | MP0005275_abnormal_skin_tensile | 0.77756274 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76371496 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.75688403 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.75640749 |
| 114 | MP0005023_abnormal_wound_healing | 0.75328467 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.73602037 |
| 116 | MP0002254_reproductive_system_inflammat | 0.73452692 |
| 117 | MP0005166_decreased_susceptibility_to | 0.72027232 |
| 118 | MP0002095_abnormal_skin_pigmentation | 0.71523308 |
| 119 | MP0003567_abnormal_fetal_cardiomyocyte | 0.71275657 |
| 120 | MP0008438_abnormal_cutaneous_collagen | 0.70868452 |
| 121 | MP0009931_abnormal_skin_appearance | 0.69868024 |
| 122 | MP0010771_integument_phenotype | 0.69794815 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.69514274 |
| 124 | MP0000013_abnormal_adipose_tissue | 0.69146836 |
| 125 | MP0004272_abnormal_basement_membrane | 0.68125281 |
| 126 | MP0001697_abnormal_embryo_size | 0.67779190 |
| 127 | MP0000685_abnormal_immune_system | 0.67595975 |
| 128 | MP0001756_abnormal_urination | 0.67129753 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.66183984 |
| 130 | MP0005501_abnormal_skin_physiology | 0.65578870 |
| 131 | MP0000049_abnormal_middle_ear | 0.65488844 |
| 132 | MP0002139_abnormal_hepatobiliary_system | 0.65055127 |
| 133 | MP0009643_abnormal_urine_homeostasis | 0.65026278 |
| 134 | MP0005670_abnormal_white_adipose | 0.64800999 |
| 135 | MP0001529_abnormal_vocalization | 0.64305989 |
| 136 | MP0000716_abnormal_immune_system | 0.63713072 |
| 137 | MP0000537_abnormal_urethra_morphology | 0.63443270 |
| 138 | MP0005330_cardiomyopathy | 0.62594465 |
| 139 | MP0009115_abnormal_fat_cell | 0.62325868 |
| 140 | MP0001915_intracranial_hemorrhage | 0.60971578 |
| 141 | MP0003329_amyloid_beta_deposits | 0.60751477 |
| 142 | MP0002971_abnormal_brown_adipose | 0.59714783 |
| 143 | MP0002135_abnormal_kidney_morphology | 0.58750385 |
| 144 | MP0010352_gastrointestinal_tract_polyps | 0.58386242 |
| 145 | MP0008875_abnormal_xenobiotic_pharmacok | 0.57735202 |
| 146 | MP0001533_abnormal_skeleton_physiology | 0.56644291 |
| 147 | MP0005376_homeostasis/metabolism_phenot | 0.55647471 |
| 148 | MP0000598_abnormal_liver_morphology | 0.54576823 |
| 149 | MP0000604_amyloidosis | 0.54295813 |
| 150 | MP0000609_abnormal_liver_physiology | 0.52578718 |
| 151 | MP0002970_abnormal_white_adipose | 0.51775981 |
| 152 | MP0003172_abnormal_lysosome_physiology | 0.51381063 |
| 153 | MP0000477_abnormal_intestine_morphology | 0.50523169 |
| 154 | MP0003221_abnormal_cardiomyocyte_apopto | 0.48925273 |
| 155 | MP0002166_altered_tumor_susceptibility | 0.48282785 |
| 156 | MP0005360_urolithiasis | 0.46296144 |
| 157 | MP0009785_altered_susceptibility_to | 0.46118676 |
| 158 | MP0010307_abnormal_tumor_latency | 0.46027355 |
| 159 | MP0003866_abnormal_defecation | 0.45420929 |
| 160 | MP0001873_stomach_inflammation | 0.43794678 |
| 161 | MP0005671_abnormal_response_to | 0.43232168 |
| 162 | MP0003123_paternal_imprinting | 0.42689614 |
| 163 | MP0000858_altered_metastatic_potential | 0.42535988 |
| 164 | MP0005384_cellular_phenotype | 0.42438158 |
| 165 | MP0002089_abnormal_postnatal_growth/wei | 0.41499587 |
| 166 | MP0000747_muscle_weakness | 0.41116964 |
| 167 | MP0002269_muscular_atrophy | 0.40690813 |
| 168 | MP0002405_respiratory_system_inflammati | 0.40615130 |
| 169 | MP0005025_abnormal_response_to | 0.40384975 |
| 170 | MP0000465_gastrointestinal_hemorrhage | 0.39815881 |
| 171 | MP0001145_abnormal_male_reproductive | 0.39613673 |
| 172 | MP0008873_increased_physiological_sensi | 0.39459263 |
| 173 | MP0005464_abnormal_platelet_physiology | 0.39368684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 9.09305040 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 8.82075295 |
| 3 | Malnutrition (HP:0004395) | 6.41022364 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.35725509 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 4.96957365 |
| 6 | Pallor (HP:0000980) | 4.53166111 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.42156694 |
| 8 | Reticulocytopenia (HP:0001896) | 4.35401323 |
| 9 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.18386426 |
| 10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.18386426 |
| 11 | Poikilocytosis (HP:0004447) | 4.16200580 |
| 12 | Abnormality of proline metabolism (HP:0010907) | 4.11906812 |
| 13 | Hydroxyprolinuria (HP:0003080) | 4.11906812 |
| 14 | Abnormality of reticulocytes (HP:0004312) | 4.02984546 |
| 15 | Increased serum ferritin (HP:0003281) | 4.00444253 |
| 16 | Aplastic anemia (HP:0001915) | 3.84931052 |
| 17 | Reticulocytosis (HP:0001923) | 3.84750109 |
| 18 | Hepatocellular necrosis (HP:0001404) | 3.80426826 |
| 19 | Mitochondrial inheritance (HP:0001427) | 3.66860515 |
| 20 | Macrocytic anemia (HP:0001972) | 3.54945284 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.53482923 |
| 22 | Acute necrotizing encephalopathy (HP:0006965) | 3.50398591 |
| 23 | Increased CSF lactate (HP:0002490) | 3.47773979 |
| 24 | Hepatic necrosis (HP:0002605) | 3.41879759 |
| 25 | Abnormality of iron homeostasis (HP:0011031) | 3.37580182 |
| 26 | Widely patent fontanelles and sutures (HP:0004492) | 3.36007268 |
| 27 | Thin bony cortex (HP:0002753) | 3.35641006 |
| 28 | Oral leukoplakia (HP:0002745) | 3.32781951 |
| 29 | Acanthocytosis (HP:0001927) | 3.30757340 |
| 30 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.29797692 |
| 31 | Increased serum lactate (HP:0002151) | 3.19821975 |
| 32 | Petechiae (HP:0000967) | 3.16649034 |
| 33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.14320279 |
| 34 | Abnormality of alanine metabolism (HP:0010916) | 3.14320279 |
| 35 | Hyperalaninemia (HP:0003348) | 3.14320279 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.12856924 |
| 37 | Acute encephalopathy (HP:0006846) | 3.10046061 |
| 38 | Increased intramyocellular lipid droplets (HP:0012240) | 3.01936373 |
| 39 | Confusion (HP:0001289) | 2.98159645 |
| 40 | Atrophic scars (HP:0001075) | 2.96413157 |
| 41 | Hyperbilirubinemia (HP:0002904) | 2.95916105 |
| 42 | Hemorrhage of the eye (HP:0011885) | 2.95242524 |
| 43 | Increased muscle lipid content (HP:0009058) | 2.94671610 |
| 44 | Microretrognathia (HP:0000308) | 2.94555320 |
| 45 | Lactic acidosis (HP:0003128) | 2.89976693 |
| 46 | Increased hepatocellular lipid droplets (HP:0006565) | 2.87626029 |
| 47 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.87516507 |
| 48 | Lipid accumulation in hepatocytes (HP:0006561) | 2.86551278 |
| 49 | Diaphragmatic weakness (HP:0009113) | 2.84561931 |
| 50 | Flat acetabular roof (HP:0003180) | 2.81643991 |
| 51 | 3-Methylglutaconic aciduria (HP:0003535) | 2.77367162 |
| 52 | Prolonged neonatal jaundice (HP:0006579) | 2.74292107 |
| 53 | Wide cranial sutures (HP:0010537) | 2.73153318 |
| 54 | Nausea (HP:0002018) | 2.70674318 |
| 55 | Milia (HP:0001056) | 2.69922655 |
| 56 | Progressive macrocephaly (HP:0004481) | 2.67902489 |
| 57 | Alopecia of scalp (HP:0002293) | 2.65470724 |
| 58 | Chronic diarrhea (HP:0002028) | 2.63249643 |
| 59 | Pili torti (HP:0003777) | 2.60724339 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.58659245 |
| 61 | Respiratory failure (HP:0002878) | 2.53580010 |
| 62 | Abdominal distention (HP:0003270) | 2.53172484 |
| 63 | Breast hypoplasia (HP:0003187) | 2.52969906 |
| 64 | Abnormality of vitamin B metabolism (HP:0004340) | 2.52530603 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.51494501 |
| 66 | Fragile nails (HP:0001808) | 2.51128109 |
| 67 | Exertional dyspnea (HP:0002875) | 2.49157545 |
| 68 | Hyperparathyroidism (HP:0000843) | 2.47837128 |
| 69 | Abnormal blistering of the skin (HP:0008066) | 2.45259332 |
| 70 | Eczematoid dermatitis (HP:0000976) | 2.42689133 |
| 71 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.41026423 |
| 72 | Respiratory difficulties (HP:0002880) | 2.39858346 |
| 73 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.39850306 |
| 74 | Ileus (HP:0002595) | 2.39668474 |
| 75 | Epidermoid cyst (HP:0200040) | 2.35694711 |
| 76 | Delayed epiphyseal ossification (HP:0002663) | 2.35557051 |
| 77 | Short middle phalanx of the 5th finger (HP:0004220) | 2.33660533 |
| 78 | Abnormality of the costochondral junction (HP:0000919) | 2.33473038 |
| 79 | Type I transferrin isoform profile (HP:0003642) | 2.33443685 |
| 80 | Pancytopenia (HP:0001876) | 2.32198898 |
| 81 | Rectal prolapse (HP:0002035) | 2.30935807 |
| 82 | Myopathic facies (HP:0002058) | 2.28834985 |
| 83 | Severe visual impairment (HP:0001141) | 2.28518673 |
| 84 | Abnormal hair laboratory examination (HP:0003328) | 2.27194353 |
| 85 | Hypolipoproteinemia (HP:0010981) | 2.26360895 |
| 86 | Hypoplasia of the pons (HP:0012110) | 2.25181693 |
| 87 | Rough bone trabeculation (HP:0100670) | 2.23980347 |
| 88 | Fat malabsorption (HP:0002630) | 2.23810446 |
| 89 | Cerebellar dysplasia (HP:0007033) | 2.21199119 |
| 90 | Exercise intolerance (HP:0003546) | 2.21083802 |
| 91 | Xanthomatosis (HP:0000991) | 2.19931899 |
| 92 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.19563311 |
| 93 | Polycythemia (HP:0001901) | 2.18139313 |
| 94 | Plantar hyperkeratosis (HP:0007556) | 2.18134431 |
| 95 | Cutaneous photosensitivity (HP:0000992) | 2.16142170 |
| 96 | Abnormality of the pons (HP:0007361) | 2.16135947 |
| 97 | Brushfield spots (HP:0001088) | 2.15801292 |
| 98 | Nephrolithiasis (HP:0000787) | 2.14446493 |
| 99 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.13018090 |
| 100 | Villous atrophy (HP:0011473) | 2.13018090 |
| 101 | Proximal tubulopathy (HP:0000114) | 2.09720128 |
| 102 | Cerebral hypomyelination (HP:0006808) | 2.08304169 |
| 103 | Poor head control (HP:0002421) | 2.06148972 |
| 104 | Flattened epiphyses (HP:0003071) | 2.06017757 |
| 105 | Microvesicular hepatic steatosis (HP:0001414) | 2.05983946 |
| 106 | Pustule (HP:0200039) | 2.04800843 |
| 107 | Abnormality of nail color (HP:0100643) | 2.03025605 |
| 108 | Selective tooth agenesis (HP:0001592) | 2.01666735 |
| 109 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 12.0585549 |
| 110 | Onycholysis (HP:0001806) | 1.97881389 |
| 111 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.97504400 |
| 112 | CNS demyelination (HP:0007305) | 1.97064113 |
| 113 | Abnormality of the acetabulum (HP:0003170) | 1.95978701 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 1.95269865 |
| 115 | Progressive muscle weakness (HP:0003323) | 1.94662648 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 1.94035981 |
| 117 | Increased IgE level (HP:0003212) | 1.93375461 |
| 118 | Renal Fanconi syndrome (HP:0001994) | 1.92250656 |
| 119 | Cerebral edema (HP:0002181) | 1.92087411 |
| 120 | Protuberant abdomen (HP:0001538) | 1.92075413 |
| 121 | Hypophosphatemia (HP:0002148) | 1.91623054 |
| 122 | Alkalosis (HP:0001948) | 1.91452524 |
| 123 | Secondary amenorrhea (HP:0000869) | 1.89663574 |
| 124 | Myelodysplasia (HP:0002863) | 1.88445728 |
| 125 | Broad palm (HP:0001169) | 1.87928342 |
| 126 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.87863853 |
| 127 | Reduced antithrombin III activity (HP:0001976) | 1.86978361 |
| 128 | Gastrointestinal dysmotility (HP:0002579) | 1.86962753 |
| 129 | Sparse eyelashes (HP:0000653) | 1.86816495 |
| 130 | Tibial bowing (HP:0002982) | 1.86534474 |
| 131 | Stridor (HP:0010307) | 1.85898790 |
| 132 | Ulnar bowing (HP:0003031) | 1.84074835 |
| 133 | Epistaxis (HP:0000421) | 1.83885528 |
| 134 | Hyperuricemia (HP:0002149) | 1.83774069 |
| 135 | Increased purine levels (HP:0004368) | 1.83774069 |
| 136 | Turricephaly (HP:0000262) | 1.82474874 |
| 137 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.81921437 |
| 138 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.81921437 |
| 139 | Abnormal protein glycosylation (HP:0012346) | 1.81921437 |
| 140 | Abnormal glycosylation (HP:0012345) | 1.81921437 |
| 141 | Emotional lability (HP:0000712) | 1.81307505 |
| 142 | Abnormality of glycolysis (HP:0004366) | 1.81242104 |
| 143 | Increased serum pyruvate (HP:0003542) | 1.81242104 |
| 144 | Pigmentary retinal degeneration (HP:0001146) | 1.79656696 |
| 145 | Hyperammonemia (HP:0001987) | 1.79225911 |
| 146 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79082239 |
| 147 | Metabolic alkalosis (HP:0200114) | 1.78753817 |
| 148 | Abnormal tarsal ossification (HP:0008369) | 1.78381212 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77979161 |
| 150 | Abnormality of the preputium (HP:0100587) | 1.77697340 |
| 151 | Multiple lipomas (HP:0001012) | 1.77319068 |
| 152 | Seborrheic dermatitis (HP:0001051) | 1.75406838 |
| 153 | Nail dystrophy (HP:0008404) | 1.74490832 |
| 154 | Hypocalcemia (HP:0002901) | 1.74074144 |
| 155 | 11 pairs of ribs (HP:0000878) | 1.73998068 |
| 156 | Abnormality of macrophages (HP:0004311) | 1.73543276 |
| 157 | Abnormal spermatogenesis (HP:0008669) | 1.73282244 |
| 158 | Hypertensive crisis (HP:0100735) | 1.71552816 |
| 159 | Congenital sensorineural hearing impairment (HP:0008527) | 1.71316383 |
| 160 | Bowed forearm bones (HP:0003956) | 1.71267483 |
| 161 | Bowing of the arm (HP:0006488) | 1.71267483 |
| 162 | Vertebral compression fractures (HP:0002953) | 1.71200160 |
| 163 | Insomnia (HP:0100785) | 1.71060772 |
| 164 | Dysostosis multiplex (HP:0000943) | 1.70932556 |
| 165 | Abnormality of nucleobase metabolism (HP:0010932) | 1.70287749 |
| 166 | Fragile skin (HP:0001030) | 1.70275227 |
| 167 | Neonatal onset (HP:0003623) | 1.69586111 |
| 168 | Focal segmental glomerulosclerosis (HP:0000097) | 1.69411234 |
| 169 | Abnormality of dental color (HP:0011073) | 1.66991767 |
| 170 | Microcytic anemia (HP:0001935) | 1.66527151 |
| 171 | Cholelithiasis (HP:0001081) | 1.65736528 |
| 172 | Abnormality of magnesium homeostasis (HP:0004921) | 1.65458923 |
| 173 | Delusions (HP:0000746) | 1.63491579 |
| 174 | Pendular nystagmus (HP:0012043) | 1.63218478 |
| 175 | Abnormal gallbladder physiology (HP:0012438) | 1.62335442 |
| 176 | Cholecystitis (HP:0001082) | 1.62335442 |
| 177 | Glycosuria (HP:0003076) | 1.61402667 |
| 178 | Abnormality of urine glucose concentration (HP:0011016) | 1.61402667 |
| 179 | Paralysis (HP:0003470) | 1.60891037 |
| 180 | Pterygium (HP:0001059) | 1.60783273 |
| 181 | Chronic otitis media (HP:0000389) | 1.59472457 |
| 182 | Slender long bone (HP:0003100) | 1.58915675 |
| 183 | Bone pain (HP:0002653) | 1.58908804 |
| 184 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.58727193 |
| 185 | Hyperphosphaturia (HP:0003109) | 1.56805273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.80484886 |
| 2 | ERN1 | 5.22240813 |
| 3 | WEE1 | 3.66394076 |
| 4 | EIF2AK1 | 3.64224213 |
| 5 | PRPF4B | 3.48541328 |
| 6 | MST1R | 3.29681125 |
| 7 | EPHA2 | 3.12049917 |
| 8 | STK16 | 3.06807439 |
| 9 | CDC7 | 2.95395509 |
| 10 | SCYL2 | 2.90333314 |
| 11 | BUB1 | 2.81486421 |
| 12 | VRK1 | 2.73878498 |
| 13 | PIM2 | 2.50766782 |
| 14 | NEK1 | 2.48201904 |
| 15 | NME1 | 2.39800186 |
| 16 | RIPK1 | 2.32227661 |
| 17 | CDK12 | 2.25292821 |
| 18 | DYRK3 | 2.14136927 |
| 19 | ACVR1B | 2.13146652 |
| 20 | NEK2 | 2.11942390 |
| 21 | CDK19 | 2.09814302 |
| 22 | SIK1 | 2.09226919 |
| 23 | EPHB2 | 1.94211904 |
| 24 | SMG1 | 1.92506936 |
| 25 | RPS6KA4 | 1.88079372 |
| 26 | KDR | 1.83412223 |
| 27 | FGFR4 | 1.78480051 |
| 28 | BRSK2 | 1.75357640 |
| 29 | SRPK1 | 1.70714252 |
| 30 | MET | 1.67761625 |
| 31 | KSR2 | 1.65438019 |
| 32 | EPHB1 | 1.61772444 |
| 33 | ICK | 1.57447923 |
| 34 | LRRK2 | 1.55493895 |
| 35 | BCKDK | 1.55493321 |
| 36 | PRKG2 | 1.54126371 |
| 37 | EPHA3 | 1.53808377 |
| 38 | IRAK3 | 1.50723647 |
| 39 | PDK2 | 1.48545214 |
| 40 | EIF2AK3 | 1.46132487 |
| 41 | TYK2 | 1.43337482 |
| 42 | MAP3K11 | 1.38083428 |
| 43 | MAP3K9 | 1.36954821 |
| 44 | MAPKAPK5 | 1.36369814 |
| 45 | MAP3K1 | 1.29869252 |
| 46 | CDK8 | 1.28476919 |
| 47 | IRAK2 | 1.22487423 |
| 48 | DDR2 | 1.21845374 |
| 49 | MAP3K10 | 1.21230749 |
| 50 | AURKB | 1.20984652 |
| 51 | PLK1 | 1.20781347 |
| 52 | EEF2K | 1.17359900 |
| 53 | CCNB1 | 1.17210585 |
| 54 | MAP3K2 | 1.15765496 |
| 55 | CDK7 | 1.14227511 |
| 56 | PIK3CG | 1.13090828 |
| 57 | ABL2 | 1.11240638 |
| 58 | ATR | 1.10135127 |
| 59 | TLK1 | 1.09612580 |
| 60 | AURKA | 1.09083542 |
| 61 | MAP3K7 | 1.09067182 |
| 62 | TNIK | 1.08956318 |
| 63 | CDK4 | 1.07725892 |
| 64 | IRAK1 | 1.05160374 |
| 65 | DYRK1B | 1.03394195 |
| 66 | RPS6KB2 | 1.02841689 |
| 67 | TTK | 1.02746106 |
| 68 | BRSK1 | 1.02670463 |
| 69 | MAP4K1 | 1.01280806 |
| 70 | PTK6 | 0.99290698 |
| 71 | MAP3K8 | 0.97135703 |
| 72 | TGFBR1 | 0.94036532 |
| 73 | STK10 | 0.93549148 |
| 74 | FLT3 | 0.93261513 |
| 75 | PDPK1 | 0.92161741 |
| 76 | LMTK2 | 0.89821405 |
| 77 | RAF1 | 0.88995167 |
| 78 | BMX | 0.88960288 |
| 79 | MAP3K3 | 0.88627451 |
| 80 | GRK6 | 0.88329624 |
| 81 | PTK2 | 0.85915640 |
| 82 | SIK3 | 0.85737667 |
| 83 | PDGFRA | 0.84399050 |
| 84 | MAP2K2 | 0.83811629 |
| 85 | MAP3K13 | 0.82541788 |
| 86 | MUSK | 0.80244909 |
| 87 | MAPKAPK3 | 0.78557356 |
| 88 | TSSK6 | 0.77573082 |
| 89 | MKNK1 | 0.77456505 |
| 90 | CSNK2A1 | 0.76796022 |
| 91 | TYRO3 | 0.76398506 |
| 92 | PBK | 0.75913888 |
| 93 | MAP2K3 | 0.74885671 |
| 94 | CDC42BPA | 0.73729988 |
| 95 | NTRK1 | 0.73615475 |
| 96 | CSNK2A2 | 0.72941550 |
| 97 | IRAK4 | 0.72379148 |
| 98 | DAPK1 | 0.71097180 |
| 99 | RPS6KA2 | 0.70658093 |
| 100 | JAK2 | 0.70543498 |
| 101 | TGFBR2 | 0.70460179 |
| 102 | TAOK1 | 0.70425972 |
| 103 | CHEK2 | 0.68590630 |
| 104 | MAP3K6 | 0.65705557 |
| 105 | PINK1 | 0.65618269 |
| 106 | PLK4 | 0.65037209 |
| 107 | PRKCI | 0.64871646 |
| 108 | PAK4 | 0.63938815 |
| 109 | STK24 | 0.62456638 |
| 110 | KIT | 0.61885909 |
| 111 | JAK3 | 0.60817869 |
| 112 | TESK1 | 0.60295071 |
| 113 | MTOR | 0.60033698 |
| 114 | RPS6KL1 | 0.58001893 |
| 115 | RPS6KC1 | 0.58001893 |
| 116 | MOS | 0.57962397 |
| 117 | ILK | 0.57574915 |
| 118 | PIM1 | 0.56765857 |
| 119 | BRAF | 0.54263394 |
| 120 | RPS6KA5 | 0.53041904 |
| 121 | CSNK1G3 | 0.52829126 |
| 122 | ATM | 0.51249151 |
| 123 | MATK | 0.50853261 |
| 124 | TBK1 | 0.49947072 |
| 125 | SIK2 | 0.49652053 |
| 126 | CHEK1 | 0.49218281 |
| 127 | PRKD2 | 0.48209062 |
| 128 | MAP2K7 | 0.47752421 |
| 129 | HIPK2 | 0.46039600 |
| 130 | TRIB3 | 0.45807731 |
| 131 | MYLK | 0.45686021 |
| 132 | LYN | 0.43175632 |
| 133 | RPS6KA6 | 0.43165585 |
| 134 | EIF2AK2 | 0.41881806 |
| 135 | ARAF | 0.41457983 |
| 136 | CSK | 0.41318870 |
| 137 | CHUK | 0.39758438 |
| 138 | RIPK4 | 0.39251786 |
| 139 | PRKCZ | 0.38865957 |
| 140 | PDK1 | 0.38598873 |
| 141 | TAOK2 | 0.37924156 |
| 142 | BTK | 0.37458305 |
| 143 | MAPK11 | 0.37291045 |
| 144 | PKN2 | 0.36894795 |
| 145 | MAP2K6 | 0.36616641 |
| 146 | TEC | 0.36340662 |
| 147 | PASK | 0.35797352 |
| 148 | PRKD1 | 0.35712588 |
| 149 | CDK2 | 0.33647150 |
| 150 | IKBKB | 0.32003796 |
| 151 | MAPK12 | 0.31864914 |
| 152 | ZAP70 | 0.30979769 |
| 153 | TESK2 | 0.30797362 |
| 154 | DYRK2 | 0.30748329 |
| 155 | AKT2 | 0.29820831 |
| 156 | MARK2 | 0.29490712 |
| 157 | PAK1 | 0.29246834 |
| 158 | RET | 0.29207760 |
| 159 | GRK1 | 0.28102477 |
| 160 | CAMK2G | 0.26960320 |
| 161 | CAMKK2 | 0.26890415 |
| 162 | RPS6KB1 | 0.26669296 |
| 163 | PDK3 | 0.26250511 |
| 164 | PDK4 | 0.26250511 |
| 165 | CSNK1G1 | 0.25943296 |
| 166 | MST4 | 0.25438373 |
| 167 | STK4 | 0.25358508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.27070154 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 5.02496518 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.42141058 |
| 4 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.41862965 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.40925461 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.35264270 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.95749257 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.95084357 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 2.86757158 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.69000983 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.62185331 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.58555162 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.56644672 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.54981276 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.45327926 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.41743604 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 2.21902199 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.04960139 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.94469050 |
| 20 | RNA transport_Homo sapiens_hsa03013 | 1.94387858 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.93985324 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.89902768 |
| 23 | Sulfur relay system_Homo sapiens_hsa04122 | 1.84370774 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.83408216 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.82955312 |
| 26 | Cell cycle_Homo sapiens_hsa04110 | 1.73135918 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.66729475 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64828558 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.64682739 |
| 30 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.58658183 |
| 31 | Purine metabolism_Homo sapiens_hsa00230 | 1.57672712 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.55432690 |
| 33 | RNA degradation_Homo sapiens_hsa03018 | 1.54957189 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54703373 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.54144577 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.52594797 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49312213 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45157380 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.39749378 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36685732 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.33716081 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29129277 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28901326 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.28397379 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28213055 |
| 46 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.24060206 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21205393 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.20849382 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.19917494 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16786453 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13777851 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13639957 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.12252126 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09560476 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01888508 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95258806 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93357735 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92338716 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89343080 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87264219 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86434374 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85656124 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84901425 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83193571 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83170848 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82981907 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77514719 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76750731 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76582003 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.76330157 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74966009 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73263031 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.71664559 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70223636 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67342007 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63415123 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.61137021 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59105822 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58871162 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57202444 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55934239 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.54178055 |
| 83 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52447350 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52384244 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49453376 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.49338305 |
| 87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46936090 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45927755 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44689514 |
| 90 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44053943 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.43747744 |
| 92 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42725418 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42716293 |
| 94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39822354 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.39200273 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.38875676 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37762169 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36872672 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35115767 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34602885 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.34133320 |
| 102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.33952931 |
| 103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33451431 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33430686 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30906463 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30128989 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29206277 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28288644 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27708409 |
| 110 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27525483 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27473456 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.27441653 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26522797 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.25931408 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25548921 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24879562 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.23591962 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23166749 |
| 119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23161349 |
| 120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.22839571 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22580457 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22482868 |
| 123 | Influenza A_Homo sapiens_hsa05164 | 0.22148314 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21827634 |
| 125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20903805 |
| 126 | Hepatitis B_Homo sapiens_hsa05161 | 0.20388765 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20027141 |
| 128 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.19790760 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19306389 |
| 130 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.19094099 |
| 131 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.19035181 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.18029480 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17790816 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.17542985 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16424251 |
| 136 | Pertussis_Homo sapiens_hsa05133 | 0.14477061 |
| 137 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.13772734 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13671530 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13225532 |
| 140 | HTLV-I infection_Homo sapiens_hsa05166 | 0.12647162 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.12252441 |
| 142 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.11295876 |
| 143 | Measles_Homo sapiens_hsa05162 | 0.11048727 |
| 144 | Lysosome_Homo sapiens_hsa04142 | 0.10591132 |
| 145 | Shigellosis_Homo sapiens_hsa05131 | 0.10560320 |
| 146 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.09391145 |
| 147 | Alcoholism_Homo sapiens_hsa05034 | 0.07489428 |
| 148 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.07285424 |
| 149 | Bladder cancer_Homo sapiens_hsa05219 | 0.06797704 |
| 150 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06221497 |
| 151 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.05297661 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04303616 |
| 153 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.04297434 |
| 154 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.04061027 |
| 155 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.02908689 |
| 156 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.02652960 |
| 157 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.00740276 |
| 158 | Tuberculosis_Homo sapiens_hsa05152 | 0.00675214 |
| 159 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.00361029 |

